Literature DB >> 30315397

In search of the representative pharmacophore hypotheses of the enzymatic proteome of Plasmodium falciparum: a multicomplex-based approach.

Anu Manhas1, Mohsin Y Lone1,2, Prakash C Jha3.   

Abstract

Drug resistance has made malaria an untreatable disease and therefore intensified the need for the development of new drugs and the identification of potential drug targets. In this pursuit, in silico efforts made in the past have not shown significant responses. Therefore, in the present work, the multicomplex-based pharmacophore modeling approach was employed to construct the pharmacophores of the 16 selected Plasmodium falciparum (Pf) targets. All the constructed hypotheses (153) were screened against a focused dataset made up of experimental actives of the chosen targets (3705 inhibitors). The rationale was to check the affinity of the inhibitors for the off-targets. Subsequently, the constructed hypotheses from each target were pooled based on the feature types and the pooled-hypotheses were then clustered to offer an insight about the pharmacophore similarity. Tanimoto similarity index was also calculated to look for the similarity among the inhibitors belonging to different Pf targets. Overall, the work was accomplished to bid healthier perceptive of the pharmacophore-based virtual screening and abet in providing guiding principles for the construction of stringent pharmacophores that can be employed for the screening.

Entities:  

Keywords:  Clustering; Enzymatic proteome; Multicomplex-based pharmacophore; Tanimoto similarity; Virtual screening

Mesh:

Substances:

Year:  2018        PMID: 30315397     DOI: 10.1007/s11030-018-9885-5

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  28 in total

Review 1.  Pharmacophore modeling and three-dimensional database searching for drug design using catalyst.

Authors:  Y Kurogi; O F Güner
Journal:  Curr Med Chem       Date:  2001-07       Impact factor: 4.530

Review 2.  History and evolution of the pharmacophore concept in computer-aided drug design.

Authors:  Osman F Güner
Journal:  Curr Top Med Chem       Date:  2002-12       Impact factor: 3.295

3.  Modeling of p38 mitogen-activated protein kinase inhibitors using the Catalyst HypoGen and k-nearest neighbor QSAR methods.

Authors:  Zhiyan Xiao; Shikha Varma; Yun-De Xiao; Alexander Tropsha
Journal:  J Mol Graph Model       Date:  2004-10       Impact factor: 2.518

4.  Comparison of conformational analysis techniques to generate pharmacophore hypotheses using catalyst.

Authors:  Rajendra Kristam; Valerie J Gillet; Richard A Lewis; David Thorner
Journal:  J Chem Inf Model       Date:  2005 Mar-Apr       Impact factor: 4.956

5.  Comparative analysis of protein-bound ligand conformations with respect to catalyst's conformational space subsampling algorithms.

Authors:  Johannes Kirchmair; Christian Laggner; Gerhard Wolber; Thierry Langer
Journal:  J Chem Inf Model       Date:  2005 Mar-Apr       Impact factor: 4.956

6.  Comparative performance assessment of the conformational model generators omega and catalyst: a large-scale survey on the retrieval of protein-bound ligand conformations.

Authors:  Johannes Kirchmair; Gerhard Wolber; Christian Laggner; Thierry Langer
Journal:  J Chem Inf Model       Date:  2006 Jul-Aug       Impact factor: 4.956

Review 7.  In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

8.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

9.  BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities.

Authors:  Tiqing Liu; Yuhmei Lin; Xin Wen; Robert N Jorissen; Michael K Gilson
Journal:  Nucleic Acids Res       Date:  2006-12-01       Impact factor: 16.971

Review 10.  In silico pharmacology for drug discovery: applications to targets and beyond.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.